Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue - Evaluations on Monocyte-Based Delivery System for the Central Nervous System.
The ability of monocytes and monocyte-derived macrophages (MDM) to travel towards chemotactic gradient, traverse tissue barriers, and accumulate precisely at diseased sites makes them attractive candidates as drug carriers and therapeutic gene delivery vehicles targeting the brain, where treatments are often hampered by the blockade of the blood brain barrier (BBB). This study was designed to fully establish an optimized cell-based delivery system using monocytes and MDM, by evaluating their homing efficiency, engraftment potential, as well as carriage and delivery ability to transport nano-scaled particles and exogenous genes into the brain, following the non-invasive intravenous (IV) cell adoptive transfer in an acute neuroinflammation mouse model induced by intracranial injection of Escherichia coli lipopolysaccharides. We demonstrated that freshly isolated monocytes had superior inflamed-brain homing ability over MDM cultured in the presence of macrophage colony stimulating factor. In addition, brain trafficking of IV infused monocytes was positively correlated with the number of adoptive transferred cells, and could be further enhanced by transient disruption of the BBB with IV administration of Mannitol, Bradykinin or Serotonin right before cell infusion. A small portion of transmigrated cells was detected to differentiate into IBA-1 positive cells with microglia morphology in the brain. Finally, with the use of superparamagnetic iron oxide nanoparticles SHP30, the ability of nanoscale agent-carriage monocytes to enter the inflamed brain region was validated. In addition, lentiviral vector DHIV-101 was used to introduce green fluorescent protein (GFP) gene into monocytes, and the exogenous GFP gene was detected in the brain at 48 hours following IV infusion of the transduced monocytes. All together, our study has set up the optimized conditions for the more-in-depth tests and development of monocyte-mediated delivery, and our data supported the notion to use monocytes as a non-invasive cell-based delivery system for the brain.
Office of Public Health Studies, University of Hawaii at Manoa, Honolulu, Hawaii, United Sates of America.|Department of Microbiology, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.
Hsin-I
0000-0002-1567-5006
HI
Tong
Office of Public Health Studies, University of Hawaii at Manoa, Honolulu, Hawaii, United Sates of America.
Wen
W
Kang
Institute for Biogenesis Research, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.
Philip M C
PM
Davy
Office of Public Health Studies, University of Hawaii at Manoa, Honolulu, Hawaii, United Sates of America.
Yingli
Y
Shi
Office of Public Health Studies, University of Hawaii at Manoa, Honolulu, Hawaii, United Sates of America.
Si
S
Sun
Institute for Biogenesis Research, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.
Richard C
RC
Allsopp
Office of Public Health Studies, University of Hawaii at Manoa, Honolulu, Hawaii, United Sates of America.
Yuanan
Y
Lu
D019264:Adoptive Transfer; D000818:Animals; D001812:Blood-Brain Barrier; D002454:Cell Differentiation; D016207:Cytokines / Q000235:genetics; D004660:Encephalitis / Q000473:pathology / Q000628:therapy*; D005260:Female; D049452:Green Fluorescent Proteins / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000166:cytology*; D053758:Nanoparticles; D012333:RNA, Messenger / Q000235:genetics; D014162:Transfection
D016207:Cytokines; D012333:RNA, Messenger; D049452:Green Fluorescent Proteins